Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin P Howden

Showing results (241-250 of 376) with videos related to

Pageof 38
Sort By:
Nature Communications|May 26, 2025
A multi-hospital, clinician-initiated bacterial genomics programme to investigate treatment failure in severe Staphylococcus aureus infectionsStefano G Giulieri, Marcel Leroi, Diane Daniel, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2025
Genomics for antimicrobial resistance-progress and future directionsNorelle L Sherry, Jean Y H Lee, Stefano G Giulieri, et al.
One Health Outlook|April 16, 2025
Extended spectrum beta-lactamase producing Escherichia coli and antimicrobial resistance gene sharing at the interface of human, poultry and environment: results of ESBL tricycle surveillance in Kathmandu, NepalJyoti Acharya, Runa Jha, Ranjan Raj Bhatta, et al.
Microbiology Spectrum|June 10, 2025
Transposon-directed insertion-site sequencing (TraDIS) analysis of <i>Enterococcus faecium</i> using nanopore sequencing and a WebAssembly analysis platformAlexandra L Krause, Wytamma Wirth, Adrianna M Turner, et al.
The Journal of Antimicrobial Chemotherapy|November 29, 2017
Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New ZealandRobyn S Lee, Torsten Seemann, Helen Heffernan, et al.
International Journal of Food Microbiology|January 18, 2021
Absence of high priority critically important antimicrobial resistance in Salmonella sp. isolated from Australian commercial egg layer environmentsTania Veltman, David Jordan, Christopher A McDevitt, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2021
Genomic Epidemiology and Antimicrobial Resistance Mechanisms of Imported Typhoid in AustraliaDanielle J Ingle, Patiyan Andersson, Mary Valcanis, et al.
Antimicrobial Resistance and Infection Control|September 3, 2024
Knowledge, attitudes, and readiness about critical antimicrobial resistant organisms among healthcare workers at colonial war memorial hospital in Fiji: a pre and post intervention studyKirsty Buising, Ravi Naidu, Shammi Prasad, et al.
The Lancet. Infectious Diseases|June 15, 2019
Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trialMarcus Y Chen, Anna McNulty, Ann Avery, et al.
Nature Communications|January 27, 2022
Optimising genomic approaches for identifying vancomycin-resistant Enterococcus faecium transmission in healthcare settingsCharlie Higgs, Norelle L Sherry, Torsten Seemann, et al.
Pageof 38

Showing results (241-250 of 376) with videos related to

Sort By:
Pageof 38
Nature Communications|May 26, 2025
A multi-hospital, clinician-initiated bacterial genomics programme to investigate treatment failure in severe Staphylococcus aureus infectionsStefano G Giulieri, Marcel Leroi, Diane Daniel, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2025
Genomics for antimicrobial resistance-progress and future directionsNorelle L Sherry, Jean Y H Lee, Stefano G Giulieri, et al.
One Health Outlook|April 16, 2025
Extended spectrum beta-lactamase producing Escherichia coli and antimicrobial resistance gene sharing at the interface of human, poultry and environment: results of ESBL tricycle surveillance in Kathmandu, NepalJyoti Acharya, Runa Jha, Ranjan Raj Bhatta, et al.
Microbiology Spectrum|June 10, 2025
Transposon-directed insertion-site sequencing (TraDIS) analysis of <i>Enterococcus faecium</i> using nanopore sequencing and a WebAssembly analysis platformAlexandra L Krause, Wytamma Wirth, Adrianna M Turner, et al.
The Journal of Antimicrobial Chemotherapy|November 29, 2017
Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New ZealandRobyn S Lee, Torsten Seemann, Helen Heffernan, et al.
International Journal of Food Microbiology|January 18, 2021
Absence of high priority critically important antimicrobial resistance in Salmonella sp. isolated from Australian commercial egg layer environmentsTania Veltman, David Jordan, Christopher A McDevitt, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2021
Genomic Epidemiology and Antimicrobial Resistance Mechanisms of Imported Typhoid in AustraliaDanielle J Ingle, Patiyan Andersson, Mary Valcanis, et al.
Antimicrobial Resistance and Infection Control|September 3, 2024
Knowledge, attitudes, and readiness about critical antimicrobial resistant organisms among healthcare workers at colonial war memorial hospital in Fiji: a pre and post intervention studyKirsty Buising, Ravi Naidu, Shammi Prasad, et al.
The Lancet. Infectious Diseases|June 15, 2019
Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trialMarcus Y Chen, Anna McNulty, Ann Avery, et al.
Nature Communications|January 27, 2022
Optimising genomic approaches for identifying vancomycin-resistant Enterococcus faecium transmission in healthcare settingsCharlie Higgs, Norelle L Sherry, Torsten Seemann, et al.
Pageof 38